| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 66,110 | 57,088 | 57,921 | 76,190 | | Cost of Revenue | 58,981 | 54,149 | 56,054 | 67,159 | | | Gross Profit | 7,129 | 2,939 | 1,867 | 9,031 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,466 | 6,418 | 6,895 | 6,116 | | Non Recurring | 4,097 | 38 | 607 | 42,080 | | Others | 5,255 | 5,200 | 5,318 | 9,097 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,648) | (8,717) | (10,953) | (48,262) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 | 5 | (484) | 40 | | Earnings Before Interest And Taxes | (8,638) | (8,712) | (11,437) | (48,222) | | Interest Expense | 1,833 | 1,848 | 1,038 | 1,135 | | Income Before Tax | (10,471) | (10,560) | (12,475) | (49,357) | | Income Tax Expense | (1,487) | 2,905 | (2,950) | (14,495) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,984) | (13,465) | (9,525) | (34,862) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,984) | (13,465) | (9,525) | (34,862) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,984) | ($13,465) | ($9,525) | ($34,862) |
|
0.11% Nasdaq 
0.01%
Income Statement
